Calliditas Therapeutics IPO Presentation Deck
Manufacturing
calliditas
Calliditas works with pharmaceutical service providers
Calliditas has since 2011 used one of the world's largest contract development and
manufacturing organizations (CDMOs) for both product development activities and
manufacturing of clinical study materials
Clinical packaging, labeling and distribution for Phase 3 will be performed by a contract
manufacturing organization (CMO) specialized in clinical study supply
In parallel to planning and set up of manufacturing activities, the CDMO will perform a
complete validation of analytical procedures for the testing and release of clinical study
materials for Phase 3
Significant novel know-how of the composition, manufacturing process and the drug
release performance of Nefecon, gained through the extensive product development
work
June 2020
36View entire presentation